炎性微环境主要组分与肿瘤

doi:10.3760/cma.j.issn.1673-422X.2014.03.003

国际肿瘤学杂志 ›› 2014, Vol. 41 ›› Issue (3): 169-172.doi: 10.3760/cma.j.issn.1673-422X.2014.03.003

炎性微环境主要组分与肿瘤

何学群, 韩克起

200433上海中医药大学附属岳阳中西医结合医院肿瘤科

出版日期:2014-03-08 发布日期:2014-03-17
通讯作者: 韩克起，E-mail：keqihan@sina.com E-mail: keqihan@sina.com

Key component of inflammatory microenvironment and tumor

HE Xue-Qun, HAN Ke-Qi

Department of Oncology, Yueyang Hosptail of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200433, China

Online:2014-03-08 Published:2014-03-17
Contact: Han Keqi, E-mail: keqihan@sina.com E-mail: keqihan@sina.com
Supported by:
国家自然科学基金（81072954）

摘要/Abstract

摘要： 以肿瘤细胞、肿瘤相关性成纤维细胞、巨噬细胞及细胞外基质等为主要组分组成的炎性微环境与肿瘤的发生发展、复发转移密切相关。诸多研究表明，炎症不仅可导致肿瘤的发生，同时在肿瘤发展过程中也多伴有炎症的存在。炎性微环境的主要组分与肿瘤细胞之间存在丰富的分子网络对话，阻断或干扰其中的一个或多个环节将有助于阻止肿瘤细胞的恶性表型和预后转归。

Abstract: Tumor microenvironment mainly consists of cancer cells, tumor associated fibroblasts, tumor associated macrophages, extracellular matrix and so on. The occurrence and development, recurrence and metastasis of cancer are closely related with its inflammatory microenvironment aroud. Many researches demonstrate that inflammatory induce the development of tumor, and at the same time it is always existed in the process of the progression of tumor. The mainly components of microenviroment have complex molecule network relationships with each other. Interdicting or disturbing one or several link of their relationships will contribute to the preventment of malignant phenotype and prognosis of cancer cells.

Key words: Neoplasms, Cytokines, Extracellular matrix, Inflammatory microenvironment

何学群, 韩克起. 炎性微环境主要组分与肿瘤[J]. 国际肿瘤学杂志, 2014, 41(3): 169-172.

HE Xue-Qun, HAN Ke-Qi. Key component of inflammatory microenvironment and tumor[J]. Journal of International Oncology, 2014, 41(3): 169-172.

参考文献

［1］ Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation［J］.Cell, 2011, 144(5)： 646-674. ［2］ Grivennikov SI, Greten FR, Karin M. Immunity,inflammation, and cancer［J］. Cell, 2010, 140(6): 883-899. ［3］ Bao B, Thakur A, Li Y, et al. The immunological contribution of NFκB within the tumor microenvironment: A potential protective role of zinc as an antitumor agent［J］. Biochim Biophy Acta, 2012, 1825(2):160-172. ［4］ Wu X, Chen X, Zhou Q, et al. Hepatocyte growth factor activates tumor stromal fibroblasts to promote tumorigenesis in gastric cancer［J］.Cancer Lett, 2013, 335(1):128-135. ［5］ Jedeszko C, Victor BC, Podgorski I, et al. Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ［J］. Cancer Res, 2009, 69(23):91489155. ［6］ Rasanen K, Vaheri A. Activation of fibroblasts in cancer stroma［J］. Exp Cell Res, 2010, 316(17):2713-2722. ［7］ Matsumoto K, Nakamura T, Sakai K, et al. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4［J］. Proteomics, 2008, 8(16):3360-3370. ［8］ Suzuki Y, Sakai K, Ueki J, et al. Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma［J］. Int J Cancer, 2010, 127(8):1948-1957. ［9］ Sakaguchi S,Yamaguchi T, Nomura T, et al. Regulatory T cells and immune tolerance［J］. Cell, 2008, 133(5):775-787. ［10］ Smith TR, Kumar V. Revival of CD8+ Tregmediated suppression［J］. Trends Immunol, 2008, 29(7):337-342. ［11］ Terme M, Chaput N, Combadiere B, et al. Regulatory T cells control dendritic cell/NK cell crosstalk in lymph nodes at the steady state by inhibiting CD4+ selfreactive T cells［J］. J Immunol， 2008， 180(7):4679-4686. ［12］ Sfanos KS, Bruno TC, Maris CH, et al. Phenotypic analysis of prostateinfiltrating lymphocytes reveals TH17 and Treg skewing［J］. Clin Cancer Res, 2008, 14(11):3254-3261. ［13］ Yang JD, Nakamura I, Roberts LR. The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets［J］. Semin Cancer Biol, 2011, 21(1):35-43. ［14］ Marigo I, Dolcetti L, Serafini P, et al. Tumorinduced tolerance and immune suppression by myeloid derived suppressor cells［J］. Immunol Rev, 2008, 222:162-179. ［15］ Gabrilovich DI, Nagaraj S. Myeloidderived suppressor cells as regulators of the immune system［J］. Nat Rev Immunol, 2009, 9(3):162-174. ［16］ Gabrilovich DI, Nagaraj S. Myeloidderived suppressor cells as regulators of the immune system［J］. Nat Rev Immunol, 2009, 9(3):162-174. ［17］ Nagaraj S, Gabrilovich DI. Myeloidderived suppressor cells in human cancer［J］. Cancer J, 2010, 16(4):348-353. ［18］ Serafini P, Mgebroff S, Noonan K, et al. Myeloidderived suppressor cells promote crosstolerance in B-cell lymphoma by expanding regulatory T cells［J］. Cancer Res, 2008, 68(13):5439-5449. ［19］ Arjaans M, Oude Munnink TH, TimmerBosscha H, et al.Transforming growth factor (TGF)β expression and activation mechanisms as potential targets for antitumor therapy and tumor imaging［J］. Pharmacol Ther, 2012, 135(2):123-132. ［20］ Curran CS, Keely PJ. Breast tumor and stromal cell responses to TGFβ and hypoxia in matrix deposition［J］. Matrix Biol, 2013, 32(2):95-105. ［21］ Wang X, Belguise K, O′Neill CF, et al. RelB NF-kappaB represses estrogen receptor alpha expression via induction of the zinc finger protein Blimp1［J］. Mol Cell Biol, 2009, 29(14):3832-3844. ［22］ Aggarwal BB, Kunnumakkara AB, Harikumar KB, et al. Signal transducer and activator of transcription3, inflammation, and cancer: how intimate is the relationship?［J］. Ann NY Acad Sci, 2009,1171:59-76. ［23］ Li N, Grivennikov SI, Karin M. The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment［J］. Cancer Cell, 2011, 19(4):429-431.

炎性微环境主要组分与肿瘤

Key component of inflammatory microenvironment and tumor

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

编辑推荐

Metrics

本文评价